Curis

$1.18
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.01 (+0.85%) Today
$0.00 (0.00%) As of 8:00 PM EDT after-hours

Why Robinhood?

You can buy or sell Curis and other stocks, options, and ETFs commission-free!

About CRIS

Curis, Inc. engages in the development and commercialization of drug candidates for the treatment of human cancers. Its pipeline includes CUDC-907, CA-4948, CA-170, and CA-327. Read More The CUDC-907 pipeline is an orally available small molecule inhibitor of HDAC and PI3K enzymes. The CA-170 pipeline is an also an orally-available small molecule antagonist of PD-L1 and VISTA immune checkpoints. The company was founded on February 14, 2000 and is headquartered in Lexington, MA. The listed name for CRIS is Curis, Inc. Common Stock.

Employees
28
Headquarters
Lexington, Massachusetts
Founded
2000
Market Cap
63.56M
Price-Earnings Ratio
Dividend Yield
Average Volume
570.71K
High Today
$1.21
Low Today
$1.16
Open Price
$1.17
Volume
270.55K
52 Week High
$3.59
52 Week Low
$0.62

Collections

CRIS Earnings

-$0.28
-$0.19
-$0.09
$0.00
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Estimated
per share
Actual
Expected Nov 3, After Hours

You May Also Like